Ym Biosciences Announces Nimotuzumab Presentations to be Made at the 100TH Annual Meeting of the American Association for Cancer Research and European Society for Medical Oncology
YM BioSciences Inc. (NYSE Alternext US:YMI, TSX:YM, AIM:YMBA), an oncology company that identifies, develops and commerc…